Phosphodiesterase 4 inhibitor plus metformin is superior to metformin alone for the treatment of polycystic ovary syndrome: A rat model study

The role of metformin in the management of polycystic ovary syndrome (PCOS) and PCOS-related obesity remains controversial. Recent research on the treatment of PCOS-related obesity investigated novel therapeutic agents with the potential to work synergistically with metformin. The aim of the present...

Descripción completa

Detalles Bibliográficos
Autores principales: Tohma, Yusuf Aytac, Onalan, Gogsen, Tepeoglu, Merih, Bayraktar, Nilufer, Colak, Eser, Ozcimen, Emel Ebru, Zeyneloglu, Hulusi Bulent
Formato: Online Artículo Texto
Lenguaje:English
Publicado: D.A. Spandidos 2019
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6447905/
https://www.ncbi.nlm.nih.gov/pubmed/30988783
http://dx.doi.org/10.3892/etm.2019.7428

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6447905/
https://www.ncbi.nlm.nih.gov/pubmed/30988783
http://dx.doi.org/10.3892/etm.2019.7428

Ejemplares similares